Cardiology News and Research

Latest Cardiology News and Research

Exercise can reduce cannabis use in persons who don't want to stop

Vanderbilt researchers are studying heavy users of marijuana to help understand what exercise does for the brain, contributing to a field of research that uses exercise as a modality for prevention and treatment.

4 Mar 2011

VDF urges Americans to learn about risks of DVT to help prevent death

Each year between 100,000-180,000 Americans die as the result of pulmonary embolism, a complication from blood clots in the lungs. The Vascular Disease Foundation urges Americans, especially women, to learn about the risks of venous blood clots to help prevent these deaths.

3 Mar 2011

Ziehm Imaging launches next generation hybrid Vision RFD mobile C-arm

Ziehm Imaging has launched a new generation of the Ziehm Vision RFD mobile C-arm. Offering outstanding imaging and a liquid cooling system which allows it to be used over an almost unlimited period of time, the new version is an attractive choice for hybrid ORs.

3 Mar 2011

CAS is an economically attractive alternative to endarterectomy for stroke patients

Researchers determined that carotid artery stenting with embolic protection is an economically attractive alternative to endarterectomy for patients at increased surgical risk.

3 Mar 2011

BMC partners with YMCA of Greater Boston to form END Diabetes Program

In an effort to reduce the risks of diabetes and obesity while improving cardiovascular health, Boston Medical Center today announced it has partnered with the YMCA of Greater Boston to form the Exercise and Nutrition to Decrease Diabetes Program.

3 Mar 2011

New study: Talk Test is a useful indicator of VT in trained athletes

The "Talk Test" provides a simple and reliable indicator of the proper training intensity for runners, suggests a report in the March issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

3 Mar 2011

Medtronic to make nearly $4 million in 2011 to address non-communicable diseases

In its continued commitment to reduce the global burden of non-communicable diseases, Medtronic, Inc. today announced it will make nearly $4 million in Medtronic Foundation grants in 2011 to international organizations specifically to address diseases such as diabetes and heart disease in developing countries.

3 Mar 2011

Affymetrix releases complete genotyping data set on its website

Affymetrix, Inc. today announced the release of a complete data set of 5 million variants on its website.

3 Mar 2011

Scientists develop simple home-based blood pressure measuring device for diabetics

Many people get stressed when they visit the doctor, leading to blood pressure readings higher than normal. It's called "White Coat Syndrome." And since two-thirds of diabetics suffer from high blood pressure, getting accurate readings is crucial to getting proper care for them.

3 Mar 2011

New research: Weight discrimination may impact physical health

The discrimination that obese people feel, whether it is poor service at a restaurant or being treated differently in the workplace, may have a direct impact on their physical health, according to new research from Purdue University.

3 Mar 2011

Turmeric may be 'the right spice' to fight colon cancer

Turmeric, a bright yellow spice from south Asia belonging to the ginger family, is the main ingredient in curries - and ancient wisdom suggests that it's also good for your health. Taking this wisdom to the laboratory, Tel Aviv University researchers have discovered that turmeric's active ingredient called curcumin amplifies the therapeutic activity of highly toxic anti-inflammatory drugs used to fight colon cancer when used at high doses.

3 Mar 2011

Osiris completes patient enrollment in Prochymal Phase 2 trial to treat heart attack

Osiris Therapeutics, Inc., today announced that it has successfully completed enrollment in a Phase 2 clinical trial evaluating Prochymal, an adult mesenchymal stem cell therapy, in patients experiencing their first heart attack.

3 Mar 2011

Study: Men who consume non-steroidals more likely to have erectile dysfunction

Men who take non-steroidal anti-inflammatory drugs three times a day for more than three months are 2.4 times more likely to have erectile dysfunction compared to men who do not take those drugs regularly, according to a Kaiser Permanente study published online in The Journal of Urology.

3 Mar 2011

Portola, Accumetrics sign agreement to develop and supply VerifyNow System

Accumetrics, Inc., a privately-held developer and marketer of the VerifyNow System, the first rapid and easy-to-use point-of-care diagnostic system for measuring platelet reactivity to multiple antiplatelet agents, announced today that the company has signed an agreement with Portola Pharmaceuticals, Inc. to develop and supply the VerifyNow System and VerifyNowTests for use in clinical trials.

3 Mar 2011

Promising new way to lower cholesterol production

A promising new way to inhibit cholesterol production in the body has been discovered, one that may yield treatments as effective as existing medications but with fewer side-effects.

3 Mar 2011

Night shift work may reduce risk of skin cancer in women

Melatonin is known to have cancer-protective properties, and shift work can induce desynchrony of the circadian system, reducing melatonin production. Shift work has been thought to have important health impacts, with evidence linking shift work to an increased risk of several cancers including breast, endometrial, prostate, and colorectal, and non-Hodgkin lymphoma.

2 Mar 2011

Study identifies key gene mutation responsible for type 2 diabetes in nearly 10% of patients

A multinational study has identified a key gene mutation responsible for type 2 diabetes in nearly 10 percent of patients of white European ancestry.

2 Mar 2011

PreTreat Complete is now available for public to reduce migraine headaches

A new migraine supplement, PreTreat Complete, with active compounds designed to reduce the frequency and intensity of migraine headaches is now available.

2 Mar 2011

SCAI statement highlights multiple recommendations for evaluating PCI quality at cardiac facilities

Today the Society for Cardiovascular Angiography and Interventions announced the publication of recommendations for assessing and improving program quality at percutaneous coronary intervention programs at cardiac facilities.

2 Mar 2011

WARFARIN study to explore impact of genetic testing on individualized dosing

Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study was initiated in major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.

2 Mar 2011